Incorporating zebrafish omics into chemical biology and toxicology

Zebrafish

Volumn 7, Issue 1, 2010, Pages 41-52

  Sukardi, Hendrian ^a   Ung, Choong Yong ^a   Gong, Zhiyuan ^a   Lam, Siew Hong ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; DRUG SCREENING; GENE EXPRESSION PROFILING; GENETIC SCREENING; GENETICS; GENOMICS; HUMAN; METABOLISM; METHODOLOGY; ZEBRA FISH;

ANIMALS; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION PROFILING; GENETIC TESTING; GENOMICS; HUMANS; ZEBRAFISH;

DANIO RERIO;

EID: 77951685689     PISSN: 15458547     EISSN: None     Source Type: Journal    
DOI: 10.1089/zeb.2009.0636     Document Type: Article

References (69)

1. Butcher EC, Berg EL, Kunkel EJ. Systems biology in drug discovery. Nat Biotechnol 2004;22:1253-1259.
2. Harrill AH, Rusyn I. Systems biology and functional genomics approaches for the identification of cellular responses to drug toxicity. Expert Opin Drug Metab Toxicol 2008;4:1379-1389.
3. Blomme EA, Yang Y, Waring JF. Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development. Toxicol Lett 2009;186:22-31.
4. Ganter B, Tugendreich S, Pearson CI, Ayanoglu E, Baumhueter S, Bostian KA, et al. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. J Biotechnol 2005;119:219-244.
5. Parng C, Seng WL, Semino C, McGrath P. Zebrafish: a preclinical model for drug screening. Assay Drug Dev Technol 2002;1:41-48.
6. Hill AJ, Teraoka H, Heideman W, Peterson RE. Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci 2005;86:6-19.
7. Peterson RT, Shaw SY, Peterson TA, Milan DJ, Zhong TP, Schreiber SL, et al. Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat Biotechnol 2004;22:595-599.
8. Lieschke GJ, Currie PD. Animal models of human disease: zebrafish swim into view. Nat Rev Genet 2007;8:353-367.
9. Lam SH, Mathavan S, Tong Y, Li H, Karuturi RK, Wu Y, et al. Zebrafish whole-adult-organism chemogenomics for largescale predictive and discovery chemical biology. PLoS Genet 2008;4: e1000121.
10. Lam SH, Winata CL, Tong Y, Korzh S, Lim WS, Korzh V, et al. Transcriptome kinetics of arsenic-induced adaptive response in zebrafish liver. Physiol Genomics 2006;27:351-361.
11. Webb KJ, Norton WH, Trümbach D, Meijer AH, Ninkovic J, Topp S, et al. Zebrafish reward mutants reveal novel transcripts mediating the behavioral effects of amphetamine. Genome Biol 2009;10: R81.
12. Tilton F, Tilton SC, Bammler TK, Beyer R, Farin F, Stapleton PL, Gallagher EP. Transcriptional biomarkers and mechanisms of copper-induced olfactory injury in zebrafish. Environ Sci Technol 2008;42:9404-9411.
13. Tong Y, Shan T, Poh YK, Yan T, Wang H, Lam SH, Gong Z. Molecular cloning of zebrafish and medaka vitellogenin genes and comparison of their expression in response to 17beta-estradiol. Gene 2004;328:25-36.
14. Zeng Z, Shan T, Tong Y, Lam SH, Gong Z. Development of estrogen-responsive transgenic medaka for environmental monitoring of endocrine disrupters. Environ Sci Technol 2005;39:9001-9008.
15. Kausch U, Alberti M, Haindl S, Budczies J, Hock B. Biomarkers for exposure to estrogenic compounds: gene expression analysis in zebrafish (Danio rerio). Environ Toxicol 2008;23:15-24.
16. Paules R. Phenotypic anchoring: linking cause and effect. Environ Health Perspect 2003;111: A338-A339.
17. Stegmaier K, Ross KN, Colavito SA, O'Malley S, Stockwell BR, Golub TR. Gene expression-based high-throughput screening (GE-HTS) and application to leukemia differentiation. Nat Genet 2004;36:257-263.
18. Stegmaier K. Genomic approaches to small molecule discovery. Leukemia 2009;23:1226-1235.
19. Corsello SM, Roti G, Ross KN, Chow KT, Galinsky I, DeAngelo DJ, et al. Identification of AML1-ETO modulators by chemical genomics. Blood 2009;113:6193-6205.
20. Hahn CK, Ross KN, Warrington IM, Mazitschek R, Kanegai CM, Wright RD, et al. Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation. Proc Natl Acad Sci USA 2008;105:9751-9756.
21. Stegmaier K, Wong JS, Ross KN, Chow KT, Peck D, Wright RD, et al. Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma. PLoS Med 2007;4: e122.
22. Gong Z, Koh C H V, Nguyen AT, Zhan H, Li Z, Lam SH, et al. The zebrafish model for liver carcinogenesis. In: Wang XW, Grisham JW, Thorgeirsson SS, eds. Molecular Genetics of Liver Neoplasia. New York: Springer, 2010.
23. Lam SH, Wu YL, Vega VB, Miller LD, Spitsbergen J, Tong Y, et al. Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression. Nat Biotechnol 2006;24:73-75.
24. Peck D, Crawford ED, Ross KN, Stegmaier K, Golub TR, Lamb J. A method for high-throughput gene expression signature analysis. Genome Biol 2006;7: R61.
25. Haining WN, Angelosanto J, Brosnahan K, Ross K, Hahn C, Russell K, et al. High-throughput gene expression profiling of memory differentiation in primary human T cells. BMC Immunol 2008;9:44.
26. Yang L, Kemadjou JR, Zinsmeister C, Bauer M, Legradi J, Müller F, et al. Transcriptional profiling reveals barcode-like toxicogenomic responses in the zebrafish embryo. Genome Biol 2007;8: R227.
27. Elo B, Villano CM, Govorko D, White LA. Larval zebrafish as a model for glucose metabolism: expression of phosphoenolpyruvate carboxykinase as a marker for exposure to anti-diabetic compounds. J Mol Endocrinol 2007;38:433-440.
28. Zon LI, Le X. Potential of zebrafish for anticancer drug screening. Expert Opin Drug Discov 2008;3:1451-1460.
29. Lam SH, Krishna Murthy Karuturi R, Gong Z. Zebrafish spotted-microarray for genome-wide expression profiling experiments: data acquisition and analysis. Methods Mol Biol 2009;546:197-226.
30. Moggs JG, Tinwell H, Spurway T, Chang HS, Pate I, Lim FL, et al. Phenotypic anchoring of gene expression changes during estrogen-induced uterine growth. Environ Health Perspect 2004;112:1589-1606.
31. Gurvich N, Berman MG, Wittner BS, Gentleman RC, Klein PS, Green JB. Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo. FASEB J 2005;19:1166-1168.
32. Xu J, Srinivas BP, Tay SY, Mak A, Yu X, Lee S G P, et al. Genome-wide expression profiling in the zebrafish embryo identifies target genes regulated by hedgehog signaling during vertebrate development. Genetics 2006;174:735-752.
33. van Boxtel AL, Kamstra JH, Cenijn PH, Pieterse B, Wagner JM, Antink M, et al. Microarray analysis reveals a mechanism of phenolic polybrominated diphenylether toxicity in zebrafish. Environ Sci Technol 2008;42:1773-1779.
34. Ng AN, de Jong-Curtain TA, Mawdsley DJ, White SJ, Shin J, Appel B, et al. Formation of the digestive system in zebrafish: III. Intestinal epithelium morphogenesis. Dev Biol 2005;286:114-135.
35. Chapin RE, Adams J, Boekelheide K, Gray LE Jr., Hayward SW, Lees PS, et al. NTP-CERHR expert panel report on the reproductive and developmental toxicity of bisphenol A. Birth Defects Res B Dev Reprod Toxicol 2008;83:157-395.
36. Ruepp S, Boess F, Suter L, de Vera MC, Steiner G, Steele T, et al. Assessment of hepatotoxic liabilities by transcript profiling. Toxicol Appl Pharmacol 2005;207:161-170.
37. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 2006;313:1929-1935.
38. Hieronymus H, Lamb J, Ross KN, Peng XP, Clement C, Rodina A, et al. Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. Cancer Cell 2006;10:321-330.
39. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005;102:15545-15550.
40. Camerer E, Kolstø AB, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996;81:1-41.
41. Ananyeva NM, Kouiavskaia DV, Shima M, Saenko EL. Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque. Blood 2002;99:4475-4485.
42. Terasaka N, Hiroshima A, Ariga A, Honzumi S, Koieyama T, Inaba T, Fujiwara T. Liver X receptor agonists inhibit tissue factor expression in macrophages. FEBS J 2005;272:1546-1556.
43. Joseph SB, McKilligin E, Pei L, Watson MA, Collins AR, Laffitte BA, et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci USA 2002;99:7604-7609.
44. De Wit M, Keil D, Remmerie N, van der Ven K, van den Brandhof EJ, Knapen D, et al. Molecular targets of TBBPA in zebrafish analysed through integration of genomic and proteomic approaches. Chemosphere 2008;74:96-105.
45. Wilhelm BT, Landry JR. RNA-Seq-quantitative measurement of expression through massively parallel RNA-sequencing. Methods 2009;48:249-257.
46. Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 2009;10:57-63.
47. Hegedus Z, Zakrzewska A, Agoston VC, Ordas A, Rácz P, Mink M, et al. Deep sequencing of the zebrafish transcriptome response to mycobacterium infection. Mol Immunol 2009;46:2918-2930.
48. Meijer AH, Verbeek FJ, Salas-Vidal E, Corredor-Adámez M, Bussman J, van der Sar AM, et al. Transcriptome profiling of adult zebrafish at the late stage of chronic tuberculosis due to Mycobacterium marinum infection. Mol Immunol 2005;42:1185-1203.
49. van der Ven K, Keil D, Moens LN, Hummelen PV, van Remortel P, Maras M, De Coen W. Effects of the antidepressant mianserin in zebrafish: molecular markers of endocrine disruption. Chemosphere 2006;65:1836-1845.
50. Villeneuve L, Wang RL, Bencic DC, Biales AD, Martinović D, Lazorchak JM, et al. Altered gene expression in the brain and ovaries of zebrafish (Danio rerio) exposed to the aromatase inhibitor fadrozole: microarray analysis and hypothesis generation. Environ Toxicol Chem 2009;28:1767-1782.
51. Mattingly CJ, Hampton TH, Brothers KM, Griffin NE, Planchart A. Perturbation of defense pathways by low-dose arsenic exposure in zebrafish embryos. Environ Health Perspect 2009;117:981-987.
52. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136:215-233.
53. Cortez MA, Calin GA. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther 2009;9:703-711.
54. Cohen A, Shmoish M, Levi L, Cheruti U, Levavi-Sivan B, Lubzens E. Alterations in micro-ribonucleic acid expression profiles reveal a novel pathway for estrogen regulation. Endocrinology 2008;149:1687-1696.
55. Soares AR, Pereira PM, Santos B, Egas C, Gomes AC, Arrais J, et al. Parallel DNA pyrosequencing unveils new zebrafish microRNAs. BMC Genomics 2009;10:195.
56. Wu WW, Wang G, Baek SJ, Shen RF. Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel-or LC-MALDI TOF/TOF. J Proteome Res 2006;5:651-658.
57. Zieske, L. A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies. J Exp Bot 2006;57:1501-1508.
58. Kling P, Forlin L. Proteomic studies in zebrafish liver cells exposed to the brominated flame retardants HBCD and TBBPA. Ecotoxicol Environ Saf 2009;72:1985-1993.
59. Ong ES, Chor CF, Zou L, Ong CN. A multi-analytical approach for metabolomic profiling of zebrafish (Danio rerio) livers. Mol Biosyst 2009;5:288-298.
60. Hayashi S, Akiyama S, Tamaru Y, Takeda Y, Fujiwara T, Inoue K, et al. A novel application of metabolomics in vertebrate development. Biochem Biophys Res Commun 2009;386:268-272.
61. Stern HM, Murphey RD, Shepard JL, Amatruda JF, Straub CT, Pfaff KL, et al. Small molecules that delay S phase suppress a zebrafish bmyb mutant. Nat Chem Biol 2005;1:366-370.
62. Kily LJ, Cowe YC, Hussain O, Patel S, McElwaine S, Cotter FE, Brennan CH. Gene expression changes in a zebrafish model of drug dependency suggest conservation of neuroadaptation pathways. J Exp Biol 2008;211:1623-1634.
63. Ruggeri B, Ubaldi M, Lourdusamy A, Soverchia L, Ciccocioppo R, Hardiman G, et al. Variation of the genetic expression pattern after exposure to estradiol-17beta and 4-nonylphenol in male zebrafish (Danio rerio). Gen Comp Endocrinol 2008;158:138-144.
64. Holth TF, Nourizadeh-Lillabadi R, Blaesbjerg M, Grung M, Holbech H, Petersen GI, et al. Differential gene expression and biomarkers in zebrafish (Danio rerio) following exposure to produced water components. Aquat Toxicol 2008;90:277-291.
65. Nourizadeh-Lillabadi R, Lyche JL, Almaas C, Stavik B, Moe SJ, Aleksandersen M, et al. Transcriptional regulation in liver and testis associated with developmental and reproductive effects in male zebrafish exposed to natural mixtures of persistent organic pollutants (POP). J Toxicol Environ Health A 2009;72:112-130.
66. Shrader EA, Henry TR, Greeley MS Jr., Bradley BP. Proteomics in zebrafish exposed to endocrine disrupting chemicals. Ecotoxicology 2003;12:485-488.
67. Damodaran S, Dlugos CA, Wood TD, Rabin RA. Effects of chronic ethanol administration on brain protein levels: a proteomic investigation using 2-D DIGE system. Eur J Pharmacol 2006;547:75-82.
68. Gündel U, Benndorf D, von Bergen M, Altenburger R, Kü ster E. Vitellogenin cleavage products as indicators for toxic stress in zebrafish embryos: a proteomic approach. Proteomics 2007;7:4541-4554.
69. Shi X, Yeung LW, Lam PK, Wu RS, Zhou B. Protein profiles in zebrafish (Danio rerio) embryos exposed to perfluorooctane sulfonate. Toxicol Sci 2009;110:334-340.